238
Views
14
CrossRef citations to date
0
Altmetric
Review

Effects of TNFα inhibitors on adiposity and other cardiovascular risk factors: implications for the cardiovascular prognosis in patients with rheumatoid arthritis

, MD PhD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Eric Toussirot, Charline Vauchy, Delphine Binda & Fabrice Michel. (2016) Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials. Drug Design, Development and Therapy 10, pages 2087-2094.
Read now

Articles from other publishers (13)

Dražen Bedeković, Ivica Bošnjak, Sandra Šarić, Damir Kirner & Srđan Novak. (2023) Role of Inflammatory Cytokines in Rheumatoid Arthritis and Development of Atherosclerosis: A Review. Medicina 59:9, pages 1550.
Crossref
怡静 宋. (2023) The Correlation of Rheumatoid Arthritis with Coronary Heart Disease. Advances in Clinical Medicine 13:03, pages 4244-4252.
Crossref
Mariana Peixoto Guimarães Ubirajara de Souza, Nathalia Sernizon Guimarães, Maria Fernanda Brandão de Resende Guimarães, Viviane Angelina de Souza & Adriana Maria Kakehasi. (2022) Effect of biological disease-modifying antirheumatic drugs on body composition in patients with rheumatoid arthritis: a systematic review and meta-analysis. Advances in Rheumatology 62:1.
Crossref
Mir Sohail Fazeli, Vadim Khaychuk, Keith Wittstock, Boris Breznen, Grace Crocket, Mir-Masoud Pourrahmat & Leticia Ferri. (2021) Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors, Autoantibodies, and the Effect of Antirheumatic Therapies. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 14, pages 117954412110287.
Crossref
Tapan Behl, Ishnoor Kaur, Aayush Sehgal, Gokhan Zengin, Ciprian Brisc, Mihaela Cristina Brisc, Mihai Alexandru Munteanu, Delia Carmen Nistor-Cseppento & Simona Bungau. (2020) The Lipid Paradox as a Metabolic Checkpoint and Its Therapeutic Significance in Ameliorating the Associated Cardiovascular Risks in Rheumatoid Arthritis Patients. International Journal of Molecular Sciences 21:24, pages 9505.
Crossref
Manca Ogrič, Katjuša Mrak Poljšak, Katja Lakota, Polona Žigon, Sonja Praprotnik, Snezna Sodin Semrl & Saša Čučnik. (2019) Neutralizing effects of anti-infliximab antibodies on synergistically-stimulated human coronary artery endothelial cells. Atherosclerosis 291, pages 1-8.
Crossref
T. Dimitroulas, A. Sandoo, S. Skeoch, M. O’Sullivan, M. Yessirkepov, L. Ayvazyan, A.Y. Gasparyan, G. Metsios & G.D. Kitas. 2017. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases 129 165 .
Deborah Palmer & Yasser El Miedany. 2017. Comorbidity in Rheumatic Diseases. Comorbidity in Rheumatic Diseases 381 403 .
Marloes van Onna & Annelies Boonen. (2016) The challenging interplay between rheumatoid arthritis, ageing and comorbidities. BMC Musculoskeletal Disorders 17:1.
Crossref
Chen-Ming Su, Chun-Yin Huang & Chih-Hsin Tang. (2016) Characteristics of resistin in rheumatoid arthritis angiogenesis. Biomarkers in Medicine 10:6, pages 651-660.
Crossref
F. Saad, A. Haider & L. Gooren. (2016) Hypogonadal men with psoriasis benefit from long-term testosterone replacement therapy - a series of 15 case reports. Andrologia 48:3, pages 341-346.
Crossref
?ric Toussirot. (2016) Ob?sit? et r?ponse aux agents th?rapeutiques des rhumatismes inflammatoires chroniques. Revue du Rhumatisme Monographies 83:1, pages 37-43.
Crossref
Catherine M. McGrath & Stephen P. Young. (2015) Lipid and Metabolic Changes in Rheumatoid Arthritis. Current Rheumatology Reports 17:9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.